Deborah L Tanner Insider Trading
Get free email notifications about insider trading for Deborah L Tanner.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Deborah L Tanner. Deborah L Tanner is a CEO, Covance Drug Development in LABORATORY CORP OF AMERICA HOLDINGS ($LH) and a in WEST PHARMACEUTICAL SERVICES INC ($WST) and an Corp. Executive Vice President in COVANCE INC ($CVD) and a Corporate Sr. Vice President in COVANCE INC ($CVD).
Address: COVANCE INC. 210 CARNEGIE CENTER PRINCETON 08540-6233 NJ
Companies in which Deborah L Tanner is an Insider
COVANCE INC
Trading Symbol: CVDIndustry: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
Position of Deborah L Tanner: Corp. Executive Vice President, Corporate Sr. Vice President
Holdings: 0 shares
Latest Transaction: Feb 23 2015
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
LABORATORY CORP OF AMERICA HOLDINGS
Trading Symbol: LHIndustry: SERVICES-MEDICAL LABORATORIES [8071]
Position of Deborah L Tanner: CEO, Covance Drug Development
Holdings: 19,754 shares
Current Value: $2,565,254
Latest Transaction: Mar 15 2016
$LH Market Capitalization: $13.45B
$LH Previous Close: $129.86
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
WEST PHARMACEUTICAL SERVICES INC
Trading Symbol: WSTIndustry: FABRICATED RUBBER PRODUCTS, NEC [3060]
Position of Deborah L Tanner:
Holdings: 7,774 shares
Current Value: $665,921
Latest Transaction: May 06 2021
$WST Market Capitalization: $6.29B
$WST Previous Close: $85.66
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Deborah L Tanner
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 06 2021 | WST | WEST PHARMACEUTICA ... | Keller Deborah L | Grant | A | 0.00 | 577 | 0 | 7,774 | 7.2 K to 7.8 K (+8.02 %) | |
May 07 2020 | WST | WEST PHARMACEUTICA ... | Keller Deborah L | Grant | A | 0.00 | 975 | 0 | 7,180 | 6.2 K to 7.2 K (+15.71 %) | |
May 09 2019 | WST | WEST PHARMACEUTICA ... | Keller Deborah L | Grant | A | 0.00 | 1,565 | 0 | 4,881 | 3.3 K to 4.9 K (+47.20 %) | |
Oct 02 2018 | WST | WEST PHARMACEUTICA ... | Keller Deborah L | Option Exercise | A | 0.00 | 162 | 0 | 1,072 | ||
Aug 01 2018 | WST | WEST PHARMACEUTICA ... | Keller Deborah L | Option Exercise | A | 0.00 | 202 | 0 | 910 | ||
Aug 01 2018 | WST | WEST PHARMACEUTICA ... | Keller Deborah L | Option Exercise | A | 0.00 | 228 | 0 | 708 | ||
Aug 01 2018 | WST | WEST PHARMACEUTICA ... | Keller Deborah L | Option Exercise | A | 0.00 | 202 | 0 | 480 |